EUVIMEDEUVIMED entdecken
Open Access

Gut Microbiome and Symptom Burden in Obese and Non-Obese Women Receiving Chemotherapy for Breast Cancer

Catherine H Cherwin iD, Jemmie Hoang, Emily K Roberts, Ashutosh Mangalam

Biological Research For Nursing · 2025-07 · 27 (3) · 411-422

DOI: 10.1177/10998004251318397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological Research For Nursing, online erschienen am 10.02.2025. Verfasst von Catherine H Cherwin und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing, University of Iowa, Iowa City, IA, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Gastrointestinal Microbiome, Obesity, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINR NIH HHS, NIEHS NIH HHS, Gastrointestinal microbiome, obesity, and chemotherapy: Influences on symptom burden in women with breast cancer receiving chemotherapy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Obese women with breast cancer experience high symptom burden, poor quality of life, and increased mortality compared to non-obese women with breast cancer. Obesity-related changes to the bacteria of the gut, the GI microbiome, may be one such mechanism for these differences in outcomes. The purpose of this work is to report symptom burden and GI microbiome composition between obese and non-obese women with breast cancer to identify potential microbial influences for symptom severity.

Methods

59 women with breast cancer (26 obese, 33 non-obese) provided symptom reports using the Memorial Symptom Assessment Scale and stool samples for 16S analysis one week after receiving chemotherapy. Symptom reports were summarized and examined for differences based on obesity. Fecal microbiome analysis was compared between groups using alpha-diversity (Shannon index), beta-diversity (Principal Coordinate Analysis with weighted UniFrac distances), and LASSO analysis of abundance of bacterial species.

Results

While symptom burden was high, it did not differ based on obesity status. Alpha- and beta-diversity did not find significant differences based on obesity, but LASSO analysis identified eight bacteria to be significantly enriched in obese participants: Collinsella aerofacien , Prevotella 7 , Coprobacillus cateniformis , Ruminococcus torques group , Agathobacter , Frisingicoccus , Roseburia inulinivorans , and Monoglobus pectinilyticus .

Conclusions

Identifying biologic mechanisms driving symptoms is necessary for the development of therapies to reduce cancer-related symptom burden. While obesity may alter the GI microbiome and influence symptom burden in women with breast cancer, these effects may be outweighed by the effects of chemotherapy on the gut.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGastrointestinal MicrobiomeObesityAntineoplastic AgentsHumansFemaleMiddle AgedAgedAdultQuality of LifeFecesSymptom Burden

Stichwörter der Autor:innen

breast cancergastrointestinalmicrobiomeobesitysymptom burden

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • College of Nursing, University of Iowa, Iowa City, IA, USA.
  • College of Public Health Department of Biostatistics, University of Iowa, Iowa City, IA, USA.
  • Hospitals and Clinics, Department of Pathology, University of Iowa, Iowa City, IA, USA.

ORCID-Profile: Catherine H Cherwin

Förderung

  • NINR NIH HHS
  • NIEHS NIH HHS
  • Gastrointestinal microbiome, obesity, and chemotherapy: Influences on symptom burden in women with breast cancer receiving chemotherapy

Zitieren

APA

Cherwin, C. H., Hoang, J., Roberts, E. K., & Mangalam, A. (2025). Gut Microbiome and Symptom Burden in Obese and Non-Obese Women Receiving Chemotherapy for Breast Cancer. Biological Research For Nursing, 27(3), 411-422. https://doi.org/10.1177/10998004251318397

Vancouver

Cherwin CH, Hoang J, Roberts EK, Mangalam A. Gut Microbiome and Symptom Burden in Obese and Non-Obese Women Receiving Chemotherapy for Breast Cancer. Biological Research For Nursing. 2025;27(3):411-422. doi:10.1177/10998004251318397

BibTeX
@article{Cherwin2025,
  author = {Cherwin, Catherine H and Hoang, Jemmie and Roberts, Emily K and Mangalam, Ashutosh},
  title = {Gut Microbiome and Symptom Burden in Obese and Non-Obese Women Receiving Chemotherapy for Breast Cancer},
  journal = {Biological Research For Nursing},
  year = {2025},
  volume = {27},
  number = {3},
  pages = {411--422},
  doi = {10.1177/10998004251318397}
}
Kostenlos starten →